Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K230965

    Validate with FDA (Live)

    Date Cleared
    2023-06-16

    (72 days)

    Product Code
    Regulation Number
    886.5916
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Acuity™ 100 (hexafocon A) with Tangible™ Hydra-PEG® Rigid Gas Permeable Contact Lenses are indicated for daily wear for the correction of refractive error (myopia, presbyopia and/or astigmatism) in aphakic and non-aphakic persons with non-diseased eyes. The lenses may be prescribed for daily wear in otherwise non-diseased eyes that require a rigid contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery. The lens may be disinfected using a chemical disinfection system only.

    TYRO™ 97 (hofocon A) with Tangible™ Hydra-PEG® Rigid Gas Permeable Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with non-diseased eyes that are myopic, hyperopic or presbyonic and which may exhibit corneal astigmatism. Also, the lenses may be prescribed in otherwise non-diseased eyes that require a gas permeable contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery. The lenses may be disinfected only by using chemical disinfection.

    Device Description

    Acuity 100™ (hexafocon A) are available as lathe cut rigid gas permeable contact lenses for daily wear only. The lenses are manufactured from a currently marketed contact lens material, hexafocon A. comprised of a siloxanyl fluoromethacrylate copolymer (fluorosilicone acrylate monomers), tinted for visibility, and with or without UV light absorber. Non-proprietary names were assigned by the United States Adopted Names Council (USAN).

    Acuity 100™ (hexafocon A) Rigid Gas Permeable Contact Lenses are treated to incorporate Tangible™ Hydra-PEG® surface coating, which is a thin, polyethylene glycol (PEG) based polymer that is covalently bonded to the surface of the contact lens and is designed to enhance the surface properties of the contact lens while retaining the mechanical properties of the underlying material. When treated with Tangible™ Hydra-PEC® , the underlying material is encapsulated in a thin layer of polymer that results in measurable improvement of wettability (sessile drop contact angle) compared to untreated lenses.

    TYRO" -97 (hofocon A) Rigid Gas Permeable Contact Lenses are available as lathe cut rigid gas permeable contact lenses for daily wear only. The lenses are manufactured from currently marketed contact lens material. hofocon A. polymer of trifluoroethyl methacrylate and silicone methacrylate (fluorosilicone acrylate monomers), tinted for visibility, with or without UV light absorber. Non-proprietary names were assigned by the United States Adopted Names Council (USAN).

    TYRO""-97 (hofocon A) Rigid Gas Permeable Contact Lenses are treated to incorporate Tangible™ Hydra-PEG® surface coating, which is a thin, polyethylene glycol (PEG) based polymer that is covalently bonded to the surface of the contact lens and is designed to enhance the surface properties of the contact lens while retaining the mechanical properties of the underlying material. When treated with Tangible™ Hydra-PEG® .the underlying material is encapsulated in a thin laver of polymer that results in measurable improvement of wettability (sessile drop contact angle) compared to untreated lenses.

    AI/ML Overview

    This document describes the premarket notification (510(k)) for Acuity 100™ (hexafocon A) with Tangible™ Hydra-PEG® and TYRO™-97 (hofocon A) with Tangible™ Hydra-PEG® Rigid Gas Permeable Contact Lenses. The submission seeks to demonstrate substantial equivalence to previously cleared predicate devices.

    The acceptance criteria and device performance information related to this submission are described below.

    1. Table of Acceptance Criteria and Reported Device Performance

    Performance Test CategorySpecific Test/CharacteristicAcceptance Criteria (from text)Reported Device Performance (from text)
    Bench Performance Testing
    Disinfection StabilityPhysical properties after 30 disinfection cycles in Boston Simplus solution at ambient temperaturesStable physical propertiesPhysical properties stable
    Material PropertiesPhysicochemical and mechanical properties after Tangible™ Hydra-PEG® additionUnchanged (except wettability)Unchanged (except wettability)
    Wettability (Contact Angle)Sessile Drop Contact Angle - Coated<10°Acuity 100™ (hexafocon A) Coated: <10°TYRO™-97 (hofocon A) Coated: <10°
    Wettability (Contact Angle)Sessile Drop Contact Angle - Uncoated (for comparison)Not explicitly stated as acceptance criteria but used for comparisonAcuity 100™ (hexafocon A) Uncoated: 56°TYRO™-97 (hofocon A) Uncoated: 23.3°
    Aging StabilitySurface properties after 30 days of accelerated agingStable surface propertiesSurface properties stable
    BioburdenBioburden levels initially and after 30 days storage in solution<100 CFU/lensBelow acceptance criteria
    Animal Performance Testing
    Acute Ocular IrritationPer ISO 10993-23Not explicitly stated, but implies compliance with standardPerformed for both final finished subject devices
    Acute Systemic ToxicityPer ISO 10993-11Not explicitly stated, but implies compliance with standardPerformed for both final finished subject devices
    In Vitro Performance Testing
    CytotoxicityPer ISO 10993-5Not explicitly stated, but implies compliance with standardPerformed for both final finished subject devices
    Clinical Performance Testing
    Clinical Safety and EffectivenessFor finished rigid gas permeable contact lenses manufactured from Acuity™ 100 and TYRO™-97 materialsDemonstrated by predicate devicesDemonstrated by predicate devices
    Clinical Safety and EffectivenessFor contact lenses treated with Tangible™ Hydra-PEG®Previously demonstratedPreviously demonstrated

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state specific sample sizes for each test set or the exact country of origin for the data. However, it indicates that preclinical toxicology and biocompatibility tests were performed "in vitro and in vivo."

    • Bench Performance Testing: The testing involved various batches of "lenses" (e.g., 30 disinfection cycles, 30 days of accelerated aging) but specific numbers of lenses per test are not stated.
    • Animal Performance Testing: "Both the final finished subject devices" were tested, implying at least one sample of each type.
    • In Vitro Performance Testing: "Both the final finished subject devices" were tested, implying at least one sample of each type.
    • Clinical Performance Testing: This relied on the clinical safety and effectiveness previously demonstrated by predicate devices and prior submissions for Tangible™ Hydra-PEG® treated lenses. This suggests a retrospective reliance on existing clinical data rather than a new prospective clinical study for this specific submission.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This document describes a 510(k) submission for rigid gas permeable contact lenses, which primarily relies on bench testing, animal testing, and in vitro testing, along with demonstrated equivalence to predicate devices for clinical performance. The establishment of "ground truth" in the context of expert review for image-based diagnostic AI models or similar scenarios is not directly applicable here. The performance evaluation is based on objective, quantifiable physical, chemical, and biological tests following recognized ISO standards and GLP regulations.

    4. Adjudication Method for the Test Set

    Not applicable. The tests performed are objective laboratory measurements and biological assessments rather than subjective assessments requiring expert adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, What Was the Effect Size of How Much Human Readers Improve With AI vs Without AI Assistance

    Not applicable. This is not a submission for an AI-assisted diagnostic device, but rather for a physical medical device (contact lenses).

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    Not applicable. This is not an algorithm or AI-based device.

    7. The Type of Ground Truth Used (Expert Consensus, Pathology, Outcomes Data, etc.)

    The "ground truth" in this context is established by:

    • Objective measurement standards: For physical properties, wettability (sessile drop contact angle), and bioburden.
    • Compliance with recognized standards (ISO): For biocompatibility (acute ocular irritation, acute systemic toxicity, cytotoxicity).
    • Previous regulatory clearances: For the clinical safety and effectiveness of the base contact lens materials and the Tangible™ Hydra-PEG® coating, demonstrated through prior predicate device submissions.

    8. The Sample Size for the Training Set

    Not applicable. This is not a machine learning or AI device that requires a training set.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. This is not a machine learning or AI device that requires a training set.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1